BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10158131)

  • 21. Complying with US and European change control requirements, Part II.
    Donawa ME
    Med Device Technol; 1997 Nov; 8(9):13-6. PubMed ID: 10174625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public information; communications with state and foreign government officials--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(143):40069-72. PubMed ID: 10181518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical devices; humanitarian use of devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(212):59217-22. PubMed ID: 10187383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
    Food and Drug Administration. HHS
    Fed Regist; 2006 Jan; 71(10):2458-62. PubMed ID: 16479693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical devices; device tracking--FDA. Final rule; notification of status under the Safe Medical Devices Act; confirmation of effective date.
    Fed Regist; 1992 May; 57(104):22966-70. PubMed ID: 10171013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical devices; illustrative and designated lists for device tracking--FDA. Final rule and request for comments.
    Fed Regist; 1993 Aug; 58(156):43451-5. PubMed ID: 10171508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical devices; humanitarian use of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(74):19196-200. PubMed ID: 10178431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use and recognition of consensus standards in US premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Mar; 10(2):13-7. PubMed ID: 10387610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meeting European and US requirements for design and development documentation, Part I.
    Donawa ME
    Med Device Technol; 1996 Nov; 7(9):12-5. PubMed ID: 10163673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular, orthopedic, and physical medicine diagnostic devices; reclassification of cardiopulmonary bypass accessory equipment, goniometer device, and electrode cable devices. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(70):19317-9. PubMed ID: 11010630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The financing and regulation of medical devices in the United States.
    Sisk JE
    Med Prog Technol; 1982; 9(2-3):181-6. PubMed ID: 7162490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(114):34249-51. PubMed ID: 16795943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(35):8105-7. PubMed ID: 14997866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA issues final enforcement priorities for reprocessed medical devices.
    Hosp Outlook; 2000 Sep; 3(7):7, 12. PubMed ID: 11142987
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical devices: reports of corrections and removals; delay of effective data--FDA. Direct final rule; delay of effective date.
    Fed Regist; 1998 Nov; 63(222):63983. PubMed ID: 10339047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.